Background Mild cognitive impairment (MCI) is considered a preclinical stage of Alzheimer's
disease (AD). People with MCI have a higher risk of developing dementia than healthy …

Increasing evidence suggests that female individuals have a higher Alzheimer's disease
(AD) risk associated with post-menopausal loss of circulating estradiol (E2). However …

Depressive symptoms usually precede the cognitive decline in Alzheimer disease (AD) and
worsen the clinical outcome. However, the neural circuitry mediating early emotional …

Background/Objectives: Several studies have shown a relation between obesity and
cognitive decline, highlighting a significant global health challenge. In recent years, artificial …

Alzheimer's disease (AD) affects more than 40 million people worldwide and is the leading
cause of dementia. This disease is a challenge for both patients and caregivers and puts a …

Alzheimer's disease (AD) is a neurodegenerative condition that displays a high prevalence
in Lebanon causing a local burden in healthcare and socio-economic sectors. Unfortunately …

Objectives This cross-sectional study sought to evaluate the effectiveness of the Montreal
Cognitive Assessment (MoCA) and saccade in discerning the cognitive function levels …

Background As the global population ages, cognitive impairment (CI) becomes more
prevalent. Tea has been one of the most popular drinks in the world. Several studies have …

Early changes in cerebrovascular hemodynamics and endothelial function can contribute to
altered cognitive function and systemic vascular stiffness later in life. Accordingly, vascular …

Accumulation of heavy metals in the body has been shown to affect the phenotypic age
(PhenoAge). However, the combined and threshold effects of blood heavy metals on the risk …